During the past decade, AdventHealth Research Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AdventHealth Research Institute" are "Cancer" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "AdventHealth Research Institute" in a lesser frequency.

Most popular intervention types in "AdventHealth Research Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Diazepam Nasal Spray [Valtoco]" (1 trials), "TTX-080" (1 trials), "cetuximab" (1 trials) and "pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "AdventHealth Research Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AdventHealth Research Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in AdventHealth Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AdventHealth Research Institute, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

AdventHealth Research Institute has several departments that took part in Clinical trials: "AdventHealth Orlando - Investigational Drug Services" - 9 trials